Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial.

Autor: Lerario, Antonio, Worden, Francis, Ramm, Carole, Hesseltine, Elizabeth, Stadler, Walter, Else, Tobias, Shah, Manisha, Agamah, Edem, Rao, Krishna, Hammer, Gary
Zdroj: Hormones & Cancer; Dec2014, Vol. 5 Issue 6, p424-424, 1p
Databáze: Complementary Index
Externí odkaz: